Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124470503 | 12447050 | 3 | F | 20150625 | 20160801 | 20160608 | 20160804 | EXP | JP-ASTELLAS-2016JP008918AA | ASTELLAS | 74.37 | YR | M | Y | 64.00000 | KG | 20160804 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124470503 | 12447050 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 2 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 1.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 1 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 4 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 1.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 5 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 2 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 6 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 1.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 7 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 358 | MG | 204096 | 1 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
124470503 | 12447050 | 8 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 0.5 MG, ONCE DAILY | 358 | MG | 204096 | .5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | ||||
124470503 | 12447050 | 9 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | U | 0 | 4 | MG | PER ORAL NOS | QD | ||||||
124470503 | 12447050 | 10 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 1000 | MG | PER ORAL NOS | QD | ||||||
124470503 | 12447050 | 11 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 500 | MG | PER ORAL NOS | QD | ||||||
124470503 | 12447050 | 12 | C | DETANTOL | 2 | Unknown | U | 0 | 3 | MG | FORMULATION UNKNOWN | QD | |||||||
124470503 | 12447050 | 13 | C | DETANTOL | 2 | Unknown | U | 0 | 6 | MG | FORMULATION UNKNOWN | QD | |||||||
124470503 | 12447050 | 14 | C | DIOVAN | VALSARTAN | 1 | Unknown | U | 0 | 80 | MG | FORMULATION UNKNOWN | QD | ||||||
124470503 | 12447050 | 15 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Unknown | 5, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
124470503 | 12447050 | 16 | C | CALBLOCK | AZELNIDIPINE | 1 | Unknown | 16, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
124470503 | 12447050 | 17 | C | LOCHOL /00638501/ | FLUVASTATIN SODIUM | 1 | Unknown | U | 0 | 40 | MG | FORMULATION UNKNOWN | QD | ||||||
124470503 | 12447050 | 18 | C | HANP | CARPERITIDE | 1 | Intravenous drip | U | 0 | 1080 | MG | INJECTION | |||||||
124470503 | 12447050 | 19 | C | HANP | CARPERITIDE | 1 | U | 0 | INJECTION | ||||||||||
124470503 | 12447050 | 20 | C | MYOCOR | NITROGLYCERIN | 1 | Intravenous drip | U | 0 | 5 | MG | INJECTION | QD | ||||||
124470503 | 12447050 | 21 | C | LASIX | FUROSEMIDE | 1 | Intravenous drip | U | 0 | 20 | MG | INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124470503 | 12447050 | 1 | Prophylaxis against transplant rejection |
124470503 | 12447050 | 9 | Prophylaxis against transplant rejection |
124470503 | 12447050 | 10 | Prophylaxis against transplant rejection |
124470503 | 12447050 | 12 | Hypertension |
124470503 | 12447050 | 14 | Hypertension |
124470503 | 12447050 | 15 | Hypertension |
124470503 | 12447050 | 16 | Hypertension |
124470503 | 12447050 | 17 | Hyperlipidaemia |
124470503 | 12447050 | 18 | Cardiac failure |
124470503 | 12447050 | 19 | Cardiac failure |
124470503 | 12447050 | 20 | Angina pectoris |
124470503 | 12447050 | 21 | Cardiac failure |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124470503 | 12447050 | OT |
124470503 | 12447050 | HO |
124470503 | 12447050 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124470503 | 12447050 | Acute kidney injury | |
124470503 | 12447050 | Angina pectoris | |
124470503 | 12447050 | Cardiac failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124470503 | 12447050 | 1 | 20141126 | 20141203 | 0 | |
124470503 | 12447050 | 2 | 20141204 | 20141210 | 0 | |
124470503 | 12447050 | 3 | 20141211 | 20141224 | 0 | |
124470503 | 12447050 | 4 | 20141225 | 20150218 | 0 | |
124470503 | 12447050 | 5 | 20150219 | 20150422 | 0 | |
124470503 | 12447050 | 6 | 20150423 | 20150709 | 0 | |
124470503 | 12447050 | 7 | 20150710 | 20150711 | 0 | |
124470503 | 12447050 | 8 | 20150712 | 20150713 | 0 | |
124470503 | 12447050 | 10 | 2015 | 0 | ||
124470503 | 12447050 | 11 | 2015 | 0 | ||
124470503 | 12447050 | 13 | 2015 | 0 | ||
124470503 | 12447050 | 15 | 2015 | 0 | ||
124470503 | 12447050 | 16 | 2015 | 0 | ||
124470503 | 12447050 | 18 | 20150704 | 20150711 | 0 | |
124470503 | 12447050 | 20 | 20150704 | 20150711 | 0 | |
124470503 | 12447050 | 21 | 20150704 | 20150711 | 0 |